文献速递消化道肿瘤与早癌消化内镜

美国亚裔美国人胃癌内镜筛查具有成本效益

Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-07-21

研究构建决策分析马尔可夫模型,模拟50岁无症状亚裔美国人队列,比较两种内镜筛查策略与不筛查的成本效益,按性别分层。一次上消化道内镜活检并对肠化生持续监测具成本效益,而每两年内镜筛查即使结果正常也不具成本效益;中国、日本、韩国裔美国人ICER最低(均<$73,748/QALY)。

要点

  • 一次上消化道内镜活检并对胃肠化生持续监测,在50岁及以上亚裔美国人中具成本效益。
  • 每两年一次内镜筛查即使对内镜和组织病理正常者也不具成本效益。
  • 中国、日本、韩国裔美国人ICER最低,均<$73,748/QALY。

核心结论

  • 对50岁及以上美国亚裔美国人,一次内镜筛查并对胃癌癌前病变持续监测具成本效益;中国、日本、韩国裔美国人ICER最低(均<$73,748/QALY)。

研究设计与样本

  • 决策分析马尔可夫模型模拟50岁无症状亚裔美国人队列,比较两种内镜筛查策略与不筛查,按性别分层,支付意愿阈值$100,000/QALY。

主要发现

  • 与不筛查相比,一次上消化道内镜活检并对肠化生持续监测具成本效益;每两年内镜筛查即使内镜和组织病理正常也不具成本效益。
  • 中国、日本、韩国裔美国人ICER最低,均<$73,748/QALY。

关键数值与推荐

  • 成本效益以ICER报告,支付意愿阈值$100,000/QALY。
  • 一次上消化道内镜活检并对肠化生持续监测具成本效益;每两年内镜筛查不具成本效益。
  • 中国、日本、韩国裔美国人ICER均<$73,748/QALY。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic screening for gastric cancer is routine in some countries with high incidence and is associated with reduced gastric cancer-related mortality. Immigrants from countries of high incidence to low incidence of gastric cancer retain their elevated risk, but no screening recommendations have been made for these groups in the United States. We aimed to determine the cost effectiveness of different endoscopic screening strategies for noncardia gastric cancer, compared with no screening, among Chinese, Filipino, Southeast Asian, Vietnamese, Korean, and Japanese Americans. METHODS: We generated a decision-analytic Markov model to simulate a cohort of asymptomatic 50-year-old Asian Americans. The cost effectiveness of 2 distinct strategies for endoscopic gastric cancer screening was compared with no screening for each group, stratified by sex. Outcome measures were reported in incremental cost-effectiveness ratios (ICERs), with a willingness-to-pay threshold of $100,000/quality-adjusted life-year (QALY). Extensive sensitivity analyses were performed. RESULTS: Compared with performing no endoscopic gastric cancer screening, performing a 1-time upper endoscopy with biopsies, with continued endoscopic surveillance if gastric intestinal metaplasia was identified, was cost effective, whereas performing ongoing biennial endoscopies, even for patients with normal findings from endoscopy and histopathology, was not. The lowest ICERs were observed for Chinese, Japanese, and Korean Americans (all <$73,748/QALY). CONCLUSIONS: Endoscopic screening for gastric cancer with ongoing surveillance of gastric preneoplasia is cost effective for Asian Americans ages 50 years or older in the United States. The lowest ICERs were for Chinese, Japanese, and Korean Americans (all <$73,748/QALY).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Shah SC, Canakis A, Peek RM, et al. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States. Clin Gastroenterol Hepatol. 2020. PMID: 32707341. doi:10.1016/j.cgh.2020.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。